Latest Regulatory Delays News

Altamin Limited has completed its acquisition of Appian's stake in Vedra Metals, gaining 100% ownership of the Gorno Project, while advancing environmental assessments and development plans for its Lazio geothermal lithium project. A recent $3.2 million capital raise underpins its dual strategy to unlock value and progress key assets.

Titanium Sands Limited has made significant progress in securing its Industrial Mining License for the Mannar Project in Sri Lanka, while preparing for a crucial funding placement to support ongoing development.

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.

Tigers Realm Coal is finalising the sale of its Russian subsidiaries for US$49 million, pending crucial Presidential approval, while navigating recent leadership shifts.

Jameson Resources Limited has made significant progress in environmental approvals for its Crown Mountain Hard Coking Coal Project, while community and political backing for the coal sector in Canada strengthens. The company plans to resubmit its Environmental Impact Statement by mid-2025.

NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.

Black Dragon Gold's rezoning application for its flagship Salave Gold Project was rejected by local authorities, posing challenges for mining development. Meanwhile, the company secured a strategic placement raising AUD$712,000 to support ongoing operations.

NeuRizer Ltd has resolved key regulatory delays for its NeuRizer Urea Project, significantly cut operating costs, and is forging international partnerships to expand its In Situ Gasification technology.

Global Lithium Resources pauses Definitive Feasibility Study on its flagship Manna Lithium Project due to challenging lithium markets, while advancing strategic acquisitions and exploration in Western Australia.

CurveBeam AI Limited reported a remarkable 150% increase in device purchase orders in Q2 FY25, driven by strong demand for its HiRise™M platform and a new commercial agreement with Stryker. The company is advancing validation of its Enhanced HiRise™ for robotic surgical systems, despite a regulatory delay for its BMD SaaS module.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.

Asara Resources has resumed exploration activities at its flagship Kada Gold Project in Guinea, appointing key technical consultants and preparing for a targeted drilling program to upgrade its mineral resource estimate.